Open Access Highly Accessed Email this article to a friend

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer

Tsui F Cheng*, Jung D Wang and Wu C Uen

BMC Cancer 2012, 12:33 doi:10.1186/1471-2407-12-33

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?